BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 30735072)

  • 1. Fatty acid-binding protein 3 contributes to ischemic heart injury by regulating cardiac myocyte apoptosis and MAPK pathways.
    Zhuang L; Li C; Chen Q; Jin Q; Wu L; Lu L; Yan X; Chen K
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H971-H984. PubMed ID: 30735072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA LNC_000898 Alleviates Cardiomyocyte Apoptosis and Promotes Cardiac Repair After Myocardial Infarction Through Modulating the miR-375/PDK1 Axis.
    Yan M; Liu Q; Jiang Y; Wang B; Ji Y; Liu H; Xie Y
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):77-85. PubMed ID: 32398474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulating MicroRNA-203 Alleviates Myocardial Remodeling and Cell Apoptosis Through Downregulating Protein Tyrosine Phosphatase 1B in Rats With Myocardial Infarction.
    Zhang J; Pan J; Yang M; Jin X; Feng J; Wang A; Chen Z
    J Cardiovasc Pharmacol; 2019 Nov; 74(5):474-481. PubMed ID: 31725080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRMT4 overexpression aggravates cardiac remodeling following myocardial infarction by promoting cardiomyocyte apoptosis.
    Wang Y; Ju C; Hu J; Huang K; Yang L
    Biochem Biophys Res Commun; 2019 Dec; 520(3):645-650. PubMed ID: 31627895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G protein-coupled receptor kinase 5 (GRK5) contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure.
    de Lucia C; Grisanti LA; Borghetti G; Piedepalumbo M; Ibetti J; Lucchese AM; Barr EW; Roy R; Okyere AD; Murphy HC; Gao E; Rengo G; Houser SR; Tilley DG; Koch WJ
    Cardiovasc Res; 2022 Jan; 118(1):169-183. PubMed ID: 33560342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis.
    Hou L; Guo J; Xu F; Weng X; Yue W; Ge J
    Basic Res Cardiol; 2018 Jun; 113(4):28. PubMed ID: 29892894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipolin/C1q/Tnf-related protein 12 prevents adverse cardiac remodeling after myocardial infarction.
    Takikawa T; Ohashi K; Ogawa H; Otaka N; Kawanishi H; Fang L; Ozaki Y; Eguchi S; Tatsumi M; Takefuji M; Murohara T; Ouchi N
    PLoS One; 2020; 15(12):e0243483. PubMed ID: 33275602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective role of P38 MAPK during myocardial infarction via parallel activation of α-crystallin B and Nrf2.
    Mitra A; Ray A; Datta R; Sengupta S; Sarkar S
    J Cell Physiol; 2014 Sep; 229(9):1272-82. PubMed ID: 24464634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart.
    Glass C; Singla DK
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2038-49. PubMed ID: 21856911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis-Resistant Cardiac Progenitor Cells Modified With Apurinic/Apyrimidinic Endonuclease/Redox Factor 1 Gene Overexpression Regulate Cardiac Repair After Myocardial Infarction.
    Aonuma T; Takehara N; Maruyama K; Kabara M; Matsuki M; Yamauchi A; Kawabe J; Hasebe N
    Stem Cells Transl Med; 2016 Aug; 5(8):1067-78. PubMed ID: 27334489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuron-derived neurotrophic factor ameliorates adverse cardiac remodeling after experimental myocardial infarction.
    Joki Y; Ohashi K; Yuasa D; Shibata R; Kataoka Y; Kambara T; Uemura Y; Matsuo K; Hayakawa S; Hiramatsu-Ito M; Kanemura N; Ito M; Ogawa H; Daida H; Murohara T; Ouchi N
    Circ Heart Fail; 2015 Mar; 8(2):342-51. PubMed ID: 25654972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death.
    Lal H; Zhou J; Ahmad F; Zaka R; Vagnozzi RJ; Decaul M; Woodgett J; Gao E; Force T
    Circulation; 2012 Jan; 125(1):65-75. PubMed ID: 22086876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2/STAT3 signaling.
    Eid RA; Alkhateeb MA; Eleawa S; Al-Hashem FH; Al-Shraim M; El-Kott AF; Zaki MSA; Dallak MA; Aldera H
    Basic Res Cardiol; 2018 Feb; 113(2):13. PubMed ID: 29392420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction.
    Kuhn TC; Knobel J; Burkert-Rettenmaier S; Li X; Meyer IS; Jungmann A; Sicklinger F; Backs J; Lasitschka F; Müller OJ; Katus HA; Krijgsveld J; Leuschner F
    Circulation; 2020 May; 141(20):1628-1644. PubMed ID: 32100557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Runx1 Deficiency Protects Against Adverse Cardiac Remodeling After Myocardial Infarction.
    McCarroll CS; He W; Foote K; Bradley A; Mcglynn K; Vidler F; Nixon C; Nather K; Fattah C; Riddell A; Bowman P; Elliott EB; Bell M; Hawksby C; MacKenzie SM; Morrison LJ; Terry A; Blyth K; Smith GL; McBride MW; Kubin T; Braun T; Nicklin SA; Cameron ER; Loughrey CM
    Circulation; 2018 Jan; 137(1):57-70. PubMed ID: 29030345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive left ventricular remodeling, myocyte apoptosis, and protein signaling cascades after myocardial infarction in rabbits.
    Qin F; Liang MC; Liang CS
    Biochim Biophys Acta; 2005 Jun; 1740(3):499-513. PubMed ID: 15949720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury.
    Naito AT; Okada S; Minamino T; Iwanaga K; Liu ML; Sumida T; Nomura S; Sahara N; Mizoroki T; Takashima A; Akazawa H; Nagai T; Shiojima I; Komuro I
    Circ Res; 2010 Jun; 106(11):1692-702. PubMed ID: 20413784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
    Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
    Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lin28a protects against postinfarction myocardial remodeling and dysfunction through Sirt1 activation and autophagy enhancement.
    Hao Y; Lu Q; Yang G; Ma A
    Biochem Biophys Res Commun; 2016 Oct; 479(4):833-840. PubMed ID: 27693787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.